EUVIMEDEUVIMED entdecken
Crossref

Whole-cell bioconversion for producing thymoquinone by engineered Saccharomyces cerevisiae

Eunjee Kim, Minsun Kim, Min-Kyu Oh

Enzyme and Microbial Technology · 2024-08 · 178 · 110455

DOI: 10.1016/j.enzmictec.2024.110455 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Enzyme and Microbial Technology, 2024-08. Verfasst von Eunjee Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biological Engineering, Korea University, Seongbuk-gu, Seoul 02841, South Korea. Hauptthemen laut MEDLINE: Saccharomyces cerevisiae, Benzoquinones, Metabolic Engineering. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Ministry of Trade, Industry and Energy, Korea Evaluation Institute of Industrial Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thymoquinone, extracted from the black seeds of Nigella sativa, is a natural substance with highly beneficial effects against various human diseases. In this study, we aimed to construct a Saccharomyces cerevisiae strain that, produce thymoquinone from thymol, a relatively inexpensive substrate. To achieve this, cytochrome P450 from Origanum vulgare was expressed in S. cerevisiae for the bioconversion of thymol to thymoquinone, with the co-expression of cytochrome P450 reductase (CPR) from Arabidopsis thaliana, ATR1. Additionally, flexible linkers were used to connect these two enzymes. Furthermore, modifications were performed to expand the endoplasmic reticulum (ER) space, leading to increased thymoquinone production. After integrating the genes into the chromosome and optimizing the media components, a significant improvement in the thymol-to-thymoquinone conversion rate and yield were achieved. This study represents a possibility of the production of thymoquinone, a bioactive ingredient of a plant, using an engineered microbial cell.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Saccharomyces cerevisiaeBenzoquinonesMetabolic EngineeringThymolCytochrome P-450 Enzyme SystemArabidopsisArabidopsis Proteins

Stichwörter der Autor:innen

Cytochrome P450Saccharomyces cerevisiaeThymolThymoquinone

Substanzen

thymoquinoneBenzoquinonesThymolCytochrome P-450 Enzyme SystemArabidopsis Proteins

Autor:innen und Institutionen

  • Department of Chemical and Biological Engineering, Korea University, Seongbuk-gu, Seoul 02841, South Korea.
  • Department of Chemical and Biological Engineering, Korea University, Seongbuk-gu, Seoul 02841, South Korea. Electronic address: mkoh@korea.ac.kr.

Förderung

  • Ministry of Trade, Industry and Energy
  • Korea Evaluation Institute of Industrial Technology

Zitieren

APA

Kim, E., Kim, M., & Oh, M. K. (2024). Whole-cell bioconversion for producing thymoquinone by engineered Saccharomyces cerevisiae. Enzyme and Microbial Technology, 178, 110455. https://doi.org/10.1016/j.enzmictec.2024.110455

Vancouver

Kim E, Kim M, Oh MK. Whole-cell bioconversion for producing thymoquinone by engineered Saccharomyces cerevisiae. Enzyme and Microbial Technology. 2024;178:110455. doi:10.1016/j.enzmictec.2024.110455

BibTeX
@article{Kim2024,
  author = {Kim, Eunjee and Kim, Minsun and Oh, Min-Kyu},
  title = {Whole-cell bioconversion for producing thymoquinone by engineered Saccharomyces cerevisiae},
  journal = {Enzyme and Microbial Technology},
  year = {2024},
  volume = {178},
  pages = {110455},
  doi = {10.1016/j.enzmictec.2024.110455}
}
Kostenlos starten →